Financials
- Market Capitalization 1.84 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.82
ratio cours/chiffre d'affaires
29.21
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2005 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.93 USD | -1.97% | -6.51% | -19.19% | +35.39% | 1.84 B USD | ||
| 2006 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.44 USD | -2.30% | -1.13% | -15.13% | -19.18% | 1.84 B USD | ||
| 2011 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.06 USD | -5.11% | -17.33% | +8.12% | +119.94% | 1.83 B USD | ||
| 2027 | ZYME Zymeworks Inc. - Common Stock | 25.33 USD | -1.78% | -4.13% | -5.49% | +42.78% | 1.80 B USD |